AHPA Policy prohibits the sale of bulk caffeine

Market Alerts

September 2018

August 2018

July 2018

May 2018

April 2018

March 2018

February 2018

January 2018

December 2017

November 2017

October 2017

September 2017

August 2017

July 2017

June 2017

AHPA Policy prohibits the sale of bulk caffeine

Recent reports associate serious injury and death with use of pure caffeine purchased by consumers in bulk packaging

Published: Tuesday, March 24, 2015

The American Herbal Products Association (AHPA) Board of Trustees on March 4 established a trade requirement that prohibits sale by AHPA members of pure caffeine in bulk form at retail (to consumers). The policy is effective immediately and has been included in AHPA's Code of Ethics and Business Conduct. 

The AHPA Board's action came in the wake of recent reports associating serious injury and death with use of pure caffeine purchased by consumers in bulk packaging. These events also prompted several U.S. Senators to urge the Food and Drug Administration (FDA) to ban sale of bulk caffeine. See AHPA Legal Alert, 1/27/2015

AHPA members agree to comply with the Association's Code of Ethics and Business Conduct, which contains trade requirements adopted by the association. Revised on an ongoing basis, AHPA's trade requirements are created and codified when the industry determines that policies beyond those mandated by federal laws serve the common interest of the industry and our consumers.

Print

2018 Annual Fund Sponsors

   

AHPA appreciates the support of its sponsors, but does not endorse, recommend, or provide a warranty for any sponsor company, its products or services. AHPA has no responsibility for any transaction entered into with any of these companies.